Regulation of human B cell growth and differentiation: lessons from the primary immunodeficiencies.

R. Callard,S. Smith,D. J. Matthews

DOI: https://doi.org/10.1159/000058682

Abstract:

What problem does this paper attempt to address?

Nutritional Support of Cancer Patients without Oral Feeding: How to Select the Most Effective Technique?

Gonçalo Nunes,Jorge Fonseca,Ana Teresa Barata,Mário Dinis-Ribeiro,Pedro Pimentel-Nunes,Ana Teresa Barata

DOI: https://doi.org/10.1159/000502981

2019-10-07

GE Portuguese Journal of Gastroenterology

Abstract:Background: Digestive tumours are among the leading causes of morbidity and mortality. Many cancer patients cannot maintain oral feeding and develop malnutrition. The authors aim to: review the endoscopic, radiologic and surgical techniques for nutritional support in cancer patients; address the strategies for nutritional intervention according to the selected technique; and establish a decision-making algorithm to define the best approach in a specific tumour setting. Summary: This is a narrative non-systematic review based on an electronic search through the medical literature using PubMed and UpToDate. The impossibility of maintaining oral feeding is a major cause of malnutrition in head and neck (H&N) cancer, oesophageal tumours and malignant gastric outlet obstruction. Tube feeding, endoscopic stents and gastrojejunostomy are the three main nutritional options. Nasal tubes are indicated for short-term enteral feeding. Percutaneous endoscopic gastrostomy (PEG) is the gold standard when enteral nutrition is expected for more than 3–4 weeks, especially in H&N tumour and oesophageal cancer patients undergoing definite chemoradiotherapy. A gastropexy push system may be considered to avoid cancer seeding. Radiologic and surgical gastrostomy are alternatives when an endoscopic approach is not feasible. Postpyloric nutrition is indicated for patients intolerant to gastric feeding and may be achieved through nasoenteric tubes, PEG with jejunal extension, percutaneous endoscopic jejunostomy and surgical jejunostomy. Oesophageal and enteric stents are palliative techniques that allow oral feeding and improve quality of life. Surgical or EUS-guided gastrojejunostomy is recommended when enteric stents fail or prolonged survival is expected. Nutritional intervention is dependent on the technique chosen. Institutional protocols and decision algorithms should be developed on a multidisciplinary basis to optimize nutritional care. Conclusions: Gastroenterologists play a central role in the nutritional support of cancer patients performing endoscopic techniques that maintain oral or enteral feeding. The selection of the most effective technique must consider the cancer type, the oncologic therapeutic program, nutritional aims and expected patient survival.
Nutritional support via feeding jejunostomy in esophago-gastric cancers: proposal of a common working strategy based on the available evidence

Riccardo Caccialanza,Valentina Da Prat,Raffaele De Luca,Jacopo Weindelmayer,Amanda Casirati,Giovanni De Manzoni

DOI: https://doi.org/10.1007/s13304-024-02022-y

2024-11-02

Updates in Surgery

Abstract:Malnutrition is common in patients affected by esophago-gastric cancers and has a negative impact on both clinical and economic outcomes. Yet not all patients at risk of malnutrition are routinely assessed and receive appropriate support. Further, available research does not provide a mean for standardization of timing, route, and dosage for nutritional support, and this is particularly true for enteral nutrition via feeding jejunostomy. Herein, we provide an overview of the current evidence and use the gathered knowledge as a starting point for a consensus proposal. As a result, we aim to facilitate the development of appropriate and uniformed interventions, thus fulfilling the need for a multimodal therapeutic approach in these set of cancer patients.

surgery
[Nutritional Support in the Treatment of Patients with Gastrointestinal Cancer].

Guohao Wu

DOI: https://doi.org/10.3760/cma.j.issn.1671-0274.2014.10.002

2014-01-01

Abstract:Patients with gastrointestinal(GI) tract neoplasms usually suffer from malnutrition, which is associated with increased morbidity and mortality, reduction of treatment efficacy, increased risk of therapy-associated side-effects, increased length of hospital stay, and reduced quality of life. Proposing an adaptive nutritional support at each step of a multidisciplinary treatment approach for GI cancer is essential.
Nutritional Care of Gastric Cancer Patients with Clinical Outcomes and Complications: A Review

Wook Jin Choi,Jeongseon Kim

DOI: https://doi.org/10.7762/cnr.2016.5.2.65

2016-01-01

Clinical Nutrition Research

Abstract:The incidence and mortality of gastric cancer have been steadily decreased over the past few decades. However, gastric cancer is still one of the leading causes of cancer deaths across many regions of the world, particularly in Asian countries. In previous studies, nutrition has been considered one of significant risk factors in gastric cancer patients. Especially, malnourished patients are at greater risk of adverse clinical outcomes (e.g., longer hospital stay) and higher incidence of complications (e.g., wound/infectious complications) compared to well-nourished patients. Malnutrition is commonly found in advanced gastric cancer patients due to poor absorption of essential nutrients after surgery. Therefore, nutritional support protocols, such as early oral and enternal feeding, have been proposed in many studies, to improve unfavorable clinical outcomes and to reduce complications due to delayed application of oral nutritional support or parental feeding. Also, the supplied with enternal immune-enriched diet had more benefits in improving clinical outcomes and fewer complications compared to a group supplied with control formula. Using nutritional screening tools, such as nutritional risk index (NRI) and nutritional risk screening (NRS 2002), malnourished patients showed higher incidence of complications and lower survival rates than non-malnourished patients. However, a long-term nutritional intervention, such as nutritional counseling, was not effective in the patients. Therefore, early assessment of nutritional status in patients using a proper nutritional screening tool is suggested to prevent malnutrition and adverse health outcomes. Further studies with numerous ethnic groups may provide stronger scientific evidences in association between nutritional care and recovery from surgery in patients with gastric cancer.
Management of diet in gastrointestinal cancer

Clare Shaw

DOI: https://doi.org/10.1017/S0029665120007041

Abstract:Nutrition and gastrointestinal cancer are inextricably linked. The metabolic effects of cancer along with changes in dietary intake, the development of cancer cachexia and the presence of sarcopenia can influence changes in body composition. These have a negative impact on quality of life and tolerance to cancer treatment. Treatment for cancer presents some significant nutritional challenges as nutrition impact symptoms may develop, be exacerbated by treatment and may contribute to a worsening in nutritional status. Nutrition screening and assessment should be an integral part of holistic patient care. The provision of appropriate, evidence-based dietary advice should occur before, during and after cancer treatment. Appropriate and timely methods of nutritional support across the spectrum of gastrointestinal cancer are needed to ensure that people are adequately supported during courses of treatment that can span weeks and months. These can range from standard approaches of supplementing oral intake to complex interventions such as managing high output intestinal stomas. The gastrointestinal tract is particularly susceptible to impact from systemic anti-cancer treatments and radiotherapy. Gastrointestinal late effects of cancer treatment are now recognised to present particular challenges in terms of both medical and nutritional management. These late effects have a significant impact on the individual and their quality of life in addition to implications for the health service. Dietary intake following cancer treatment has an impact on quality of life and future research may demonstrate its influence on the risk of recurrence of gastrointestinal cancer.
Grade of esophageal cancer and nutritional status impact on postsurgery outcomes

Flávia Andréia Marin,Vânia Cristina Lamônica-Garcia,Maria Aparecida Coelho de Arruda Henry,Roberto Carlos Burini

DOI: https://doi.org/10.1590/s0004-28032010000400006

2010-12-01

Arquivos de Gastroenterologia

Abstract:CONTEXT: Undernutrition is a well known underlying cause in both disease onset and outcome. OBJECTIVE: To associate disease severity with pre surgical nutritional status, the main postsurgical complications, and mortality in esophagus cancer patients. METHOD: Retrospective data from 100 patients (38-81 years old, 85% males) who had undergone esophagectomy (G1/n = 25) or gastro/jejunostomy (G2/n = 75) between 1995 and 2004. Data included clinical, endoscopic, histological (TNM-UICC), dietary, anthropometric, blood chemistry, and postsurgical (>30 days) complications and mortality. Surgical groups were compared by Student's test and existing associations between variables by either c2 or Fisher exact tests with P = 0.05. RESULTS: The studied sample was predominantly male (85%), white (80%), smokers and alcoholics (95%), dysphagics (95%) mostly presenting body weight loss before cancer diagnosis (78%). TNM III and IV predominated over I and II, associated (P<0.005) with higher body mass index and hypoalbuminemia (<3.5 mg/dL) frequency. Esophagic obstructions (n = 77) were associated (P = 0.002) with lower body mass index (kg/m2). Postsurgical complications were more common in G1 (69.2%) than G2, predominantly with infections in G2 (80%) and pleura-pulmonary in G1 (61%). Body mass index and lower lymphocyte counts were associated with early infections and postsurgical complications in G2. Plasma albumin levels were lower in this group than G1, and were associated with postsurgical complications and mortality whereas lower lymphocyte counts was associated with mortality in G1. CONCLUSIONS: Disease severity (or late diagnosis) is associated with poor nutritional status and palliative surgery which lead to more complicated postsurgery outcome and mortality. Early diagnosis and nutritional intervention are the recommended actions.
The Clinical Value of Nutritional Care before and during Active Cancer Treatment

Giuseppe Aprile,Debora Basile,Renato Giaretta,Gessica Schiavo,Nicla La Verde,Ettore Corradi,Taira Monge,Francesco Agustoni,Silvia Stragliotto

DOI: https://doi.org/10.3390/nu13041196

IF: 5.9

2021-04-05

Nutrients

Abstract:Malnutrition and muscle wasting are frequently reported in cancer patients, either linked to the tumor itself or caused by oncologic therapies. Understanding the value of nutritional care during cancer treatment remains crucial. In fact, cancer-associated sarcopenia plays a key role in determining higher rates of morbidity, mortality, treatment-induced toxicities, prolonged hospitalizations and reduced adherence to anticancer treatment, worsening quality of life and survival. Planning baseline screening to intercept nutritional troubles earlier, organizing timely reassessments, and providing adequate counselling and dietary support, healthcare professional may positively interfere with this process and improve patients’ overall outcomes during the whole disease course. Several screening tools have been proposed for this purpose. Nutritional Risk Screening (NRS), Mini Nutritional Assessment (MNA), Patient Generated Subjective Global Assessment (PG-SGA) are the most common studied. Interestingly, second-level tools including skeletal muscle index (SMI) and bioelectric impedance analysis (BIA) provide a more precise assessment of body composition, even if they are more complex. However, nutritional assessment is not currently used in clinical practice and procedures must be standardized in order to improve the efficacy of standard chemotherapy, targeted agents or even checkpoint inhibitors that is potentially linked with the patients’ nutritional status. In the present review, we will discuss about malnutrition and the importance of an early nutritional assessment during chemotherapy and treatment with novel checkpoint inhibitors, in order to prevent treatment-induced toxicities and to improve survival outcomes.

nutrition & dietetics
Role of Nutritional Status in the Treatment Outcome for Esophageal Squamous Cell Carcinoma

Miao-Fen Chen,Ching-Chuan Hsieh,Ping-Tsung Chen,Ming-Shian Lu

DOI: https://doi.org/10.3390/nu13092997

IF: 5.9

2021-08-28

Nutrients

Abstract:Undernourishment is reported to impair treatment response, further leading to poor prognosis for cancer patients. We aimed to investigate the role of nutritional status on the prognosis of squamous cell carcinoma (SCC) of the esophagus, and its correlation with anticancer immune responsiveness. We retrospectively reviewed 340 esophageal-SCC patients who completed curative treatment and received a nutrition evaluation by the Patient-Generated Subjective Global Assessment (PGSGA) score at the beginning and completion of neoadjuvant treatment at our hospital. The correlation between the nutritional status and various clinicopathological parameters and prognosis were examined. In addition, the role of nutritional status in the regulation of the anticancer immune response was also assessed in cancer patients and in a 4-nitroquinoline 1-oxide (4NQO)-induced esophageal tumor model. Our data revealed that malnutrition (patients with a high PGSGA score) was associated with advanced stage and reduced survival rate. Patients in the group with a high PGSGA score were correlated with the higher neutrophil-to-lymphocyte ratio, higher proportion of myeloid-derived-suppressor cells (MDSC) and increased IL-6 level. Furthermore, surgical resection brought the survival benefit to patients in the low PGSGA group, but not for the malnourished patients after neoadjuvant treatment. Using a 4NQO-induced tumor model, we found that nutrition supplementation decreased the rate of invasive tumor formation and attenuated the immune-suppressive microenvironment. In conclusion, malnutrition was associated with poor prognosis in esophageal-SCC patients. Nutritional status evaluated by PGSGA may be useful to guide treatment decisions in clinical practice. Nutritional supplementation is suggested to improve prognosis, and it might be related to augmented anticancer immune response.
Percutaneous endoscopic gastrostomy for nutritional palliation of upper esophageal cancer unsuitable for esophageal stenting

Ana Grilo,Carla Adriana Santos,Jorge Fonseca

DOI: https://doi.org/10.1590/s0004-28032012000300012

Abstract:Context: Esophageal cancer is often diagnosed at an advanced stage and has a poor prognosis. Most patients with advanced esophageal cancer have significant dysphagia that contributes to weight loss and malnutrition. Esophageal stenting is a widespread palliation approach, but unsuitable for cancers near the upper esophageal sphincter, were stents are poorly tolerated. Generally, guidelines do not support endoscopic gastrostomy in this clinical setting, but it may be the best option for nutritional support. Objective: Retrospective evaluation of patients with dysphagia caused advanced esophageal cancer, no expectation of resuming oral intake and with percutaneous endoscopic gastrostomy for comfort palliative nutrition. Method: We selected adult patients with unresecable esophageal cancer histological confirmed, in whom stenting was impossible due to proximal location, and chemotherapy or radiotherapy were palliative, using gastrostomy for enteral nutrition. Clinical and nutritional data were evaluated, including success of gastrostomy, procedure complications and survival after percutaneous endoscopic gastrostomy, and evolution of body mass index, albumin, transferrin and cholesterol. Results: Seventeen males with stage III or IV squamous cell carcinoma fulfilled the inclusion criteria. Mean age was 60.9 years. Most of the patients had toxic habits. All underwent palliative chemotherapy or radiotherapy. Gastrostomy was successfully performed in all, but nine required prior dilatation. Most had the gastrostomy within 2 months after diagnosis. There was a buried bumper syndrome treated with tube replacement and four minor complications. There were no cases of implantation metastases or procedure related mortality. Two patients were lost and 12 died. Mean survival of deceased patients was 5.9 months. Three patients are alive 6, 14 and 17 months after the gastrostomy procedure, still increasing the mean survival. Mean body mass index and laboratory parameters were roughly stable 1 and 3 months after the gastrostomy procedure. Conclusions: In patients with advanced upper esophageal cancer where only palliative treatment is possible, nutritional support is easily achieved with percutaneous endoscopic gastrostomy, allowing patients to be at homes, surviving a significant period of time. Percutaneous endoscopic gastrostomy feeding should be considered as standard definitive nutritional palliation in patients with upper esophageal cancer, unsuitable for esophageal stenting.
T.F.J. Huda and J.E. Bowman, Age determination from dental microstructure in juveniles: American Journal of Physical Anthropology, 1995 vol. 97: 135-150.

S. Black,J. Scheuer

DOI: https://doi.org/10.1002/AJPA.1331010203

1996-10-01

American Journal of Physical Anthropology

Abstract:
Multiplex Real-Time PCR Assay for Detection of Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Suitable in Regions of High MRSA Endemicity

Jeong-Uk Kim,C. Cha,H. An,Ho-Jun Lee,Mina Kim

DOI: https://doi.org/10.1128/JCM.02495-12

2012-12-26

Journal of Clinical Microbiology

Abstract:ABSTRACT A multiplex real-time PCR assay that simultaneously detects the mecA, staphylococcal cassette chromosome (SCCmec)-open reading frame X (orfX) junction, and staphylococcal 16S rRNA genes was developed and evaluated using 444 staphylococcal strains. We demonstrated that this assay resulted in fewer false-positive results than a single-locus real-time PCR assay that amplified the SCCmec-orfX junction. This assay would be useful in a clinical laboratory in a region of high endemicity for methicillin-resistant Staphylococcus aureus (MRSA) infections.
The Role of Nutritional Support for Cancer Patients in Palliative Care

Paolo Cotogni,Silvia Stragliotto,Marta Ossola,Alessandro Collo,Sergio Riso,On Behalf Of The Intersociety Italian Working Group For Nutritional Support In Cancer,

DOI: https://doi.org/10.3390/nu13020306

IF: 5.9

2021-01-22

Nutrients

Abstract:The role of nutritional support for cancer patients in palliative care is still a controversial topic, in part because there is no consensus on the definition of a palliative care patient because of ambiguity in the common medical use of the adjective palliative. Nonetheless, guidelines recommend assessing nutritional deficiencies in all such patients because, regardless of whether they are still on anticancer treatments or not, malnutrition leads to low performance status, impaired quality of life (QoL), unplanned hospitalizations, and reduced survival. Because nutritional interventions tailored to individual needs may be beneficial, guidelines recommend that if oral food intake remains inadequate despite counseling and oral nutritional supplements, home enteral nutrition or, if this is not sufficient or feasible, home parenteral nutrition (supplemental or total) should be considered in suitable patients. The purpose of this narrative review is to identify in these cancer patients the area of overlapping between the two therapeutic approaches consisting of nutritional support and palliative care in light of the variables that determine its identification (guidelines, evidence, ethics, and law). However, nutritional support for cancer patients in palliative care may be more likely to contribute to improving their QoL when part of a comprehensive early palliative care approach.

nutrition & dietetics
A Multi-Site, International Audit of Malnutrition Risk and Energy and Protein Intakes in Patients Undergoing Treatment for Head Neck and Esophageal Cancer: Results from INFORM

Lisa Martin,Merran Findlay,Judith D Bauer,Rupinder Dhaliwal,Marian de van der Schueren,Alessandro Laviano,Adrianne Widaman,Vickie E Baracos,Andrew G Day,Leah M Gramlich

DOI: https://doi.org/10.3390/nu14245272

IF: 5.9

2022-12-10

Nutrients

Abstract:Patients with foregut tumors are at high risk of malnutrition. Nutrition care focuses on identifying individuals at risk of malnutrition and optimizing nutrient intake to promote the maintenance of body weight and lean body mass. This multi-center prospective, longitudinal study audited nutrition care practices related to screening for risk of malnutrition (Patient-Generated Subjective Global Assessment Short Form; PG-SGA SF), and nutrition interventions prescribed (route; adequacy of energy and protein intakes). Audits occurred at four time periods: baseline (before treatment) and at 2, 4, and 6 months after starting cancer treatment; 170 patients (esophageal (ESO; n = 51); head and neck (HN; n = 119)) were enrolled. Nutrition risk (PG-SGA SF score ≥ 4) was prevalent at every time period: HN (baseline: 60%; 6 months 66%) and ESO (77%; 72%). Both groups had significant (p < 0.001) weight losses over the 6 month audit period (HN = 13.2% ESO = 11.4%). Enteral nutrition (EN) was most likely to be prescribed at 2 months for HN and at 4 and 6 months for ESO. Target prescribed energy and protein intakes were not met with any nutrition intervention; although adequacy was highest for those receiving EN. Nutrition care practices differed for HN and ESO cancers and there may be time points when additional nutrition support is needed.
SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023)

Ainara Soria Rivas,Yolanda Escobar Álvarez,Ana Blasco Cordellat,Margarita Majem Tarruella,Kevin Molina Mata,Marta Motilla de la Cámara,Mª del Mar Muñoz Sánchez,Marta Zafra Poves,Carmen Beato Zambrano,Luis Cabezón Gutierrez

DOI: https://doi.org/10.1007/s12094-024-03502-8

2024-06-02

Clinical & Translational Oncology

Abstract:Cancer-related anorexia-cachexia syndrome (CACS) is a debilitating condition afflicting up to 80% of advanced-stage cancer patients. Characterized by progressive weight loss, muscle wasting, and metabolic abnormalities, CACS significantly compromises patients' quality of life and treatment outcomes. This comprehensive review navigates through its intricate physiopathology, elucidating its stages and diagnostic methodologies. CACS manifests in three distinct stages: pre-cachexia, established cachexia, and refractory cachexia. Early detection is pivotal for effective intervention and is facilitated by screening tools, complemented by nutritional assessments and professional evaluations. The diagnostic process unravels the complex interplay of metabolic dysregulation and tumor-induced factors contributing to CACS. Management strategies, tailored to individual patient profiles, encompass a spectrum of nutritional interventions. These include dietary counseling, oral nutritional supplements, and, when necessary, enteral nutrition and a judicious use of parenteral nutrition. Specific recommendations for caloric intake, protein requirements, and essential nutrients address the unique challenges posed by CACS. While pharmacological agents like megestrol acetate may be considered, their use requires careful evaluation of potential risks. At its core, this review underscores the imperative for a holistic and personalized approach to managing CACS, integrating nutritional interventions and pharmacological strategies based on a nuanced understanding of patient's condition.

oncology
Protein synthesis in axons and its possible functions

R. Campenot,H. Eng

DOI: https://doi.org/10.1023/A:1010939307434

2000-11-01

Journal of Neurocytology

Abstract:
[Tumour anorexia--tumour cachexia in case of gastrointestinal tumours: standards and visions]

J Ockenga,M Pirlich,S Gastell,H Lochs

DOI: https://doi.org/10.1055/s-2002-35411

Abstract:The development of progressive malnutrition or cachexia is frequent in patients with gastrointestinal cancer - especially in patients with a carcinoma of the pancreas. The cachexia syndrome which is characterised by loss of body weight, negative nitrogen balance and fatigue significantly affects patients' quality of life, morbidity and survival. Because the currently established therapeutical strategies are often disappointing many physicians tended to develop a therapeutical nihilism. Cancer anorexia and cachexia are two distinct syndromes which may have synergistic effects in a patient. This review highlights the growing understanding of the multidimensional pathophysiological background. An algorithm of the current treatment strategies is given. In addition, we discuss new anabolic and anticatabolic agents (e.g. eicosapentanoic acid) and the results from first clinical trials.
Malnutrition management in oncology: An expert view on controversial issues and future perspectives

Paolo Bossi,Raffaele De Luca,Oriana Ciani,Elisa D’Angelo,Riccardo Caccialanza

DOI: https://doi.org/10.3389/fonc.2022.910770

IF: 4.7

2022-10-06

Frontiers in Oncology

Abstract:Cancer and anticancer treatments can lead to several negative side effects, including malnutrition. Despite the recognized need for adequate nutritional support in cancer patients, in daily clinical practice, nutrition is still not considered one of the first aspects to be considered. Malnutrition negatively affects the clinical outcomes, treatment response, and overall survival of cancer patients. In this study, three of the most controversial issues related to malnutrition, which emerged during an Italian Consensus Conference, were addressed specifically for patients with head and neck as well as gastrointestinal cancer. The timing of nutritional evaluation and intervention, extension of the Enhanced Recovery after Surgery (ERAS ® ) protocols, and cost-effectiveness of nutritional interventions have been considered. This study aimed to illustrate the state-of-the art of each issue and hypothesize future perspectives and actions to be taken, trying to suggest a new nutritional management model for cancer patients in Italy that overcomes the critical issues encountered. Of note, the timely diagnosis of nutritional issue appears to be essential to ensure the correct management of malnourished cancer patients as well as those who are at high risk of malnutrition. Standardized protocols, screening tests, and the inclusion of nutritional parameters in patient medical records would help to achieve good clinical outcomes. Finally, appropriate nutritional support is also associated with cost savings, and it seems necessary to promote its clinical and economic value to obtain improvements in both outcomes and management costs.

oncology
Nutritional Assessment And Risk Factors Associated To Malnutrition In Patients With Esophageal Cancer

Jingjing Cao,Hongxia Xu,Wei Li,Zengqing Guo,Yuan Lin,Yingying Shi,Wen Hu,Yi Ba,Suyi Li,Zengning Li,Kunhua Wang,Jing Wu,Ying He,Jiajun Yang,Conghua Xie,Fuxiang Zhou,Xinxia Song,Gongyan Chen,Wenjun Ma,Suxia Luo,Zihua Chen,Minghua Cong,Hu Ma,Chunling Zhou,Wei Wang,Qi Luo,Yongmei Shi,Yumei Qi,Haiping Jiang,Wenxian Guan,Junqiang Chen,Jiaxin Chen,Yu Fang,Lan Zhou,Yongdong Feng,Rongshao Tan,Junwen Ou,Qingchuan Zhao,Jianxiong Wu,Xin Lin,Liuqing Yang,Zhenming Fu,Chang Wang,Li Deng,Tao Li,Chunhua Song,Hanping Shi,Investigation on Nutrition Status

DOI: https://doi.org/10.1016/j.currproblcancer.2020.100638

IF: 2.367

2021-01-01

Current Problems in Cancer

Abstract:Introduction: Esophageal cancer is the fourth most common cause of cancer death in China. Patients with esophageal cancer are more likely to suffer from malnutrition. The purpose of this study is to assess nu-tritional status of patients with esophageal cancer from multiple perspectives and analyze the risk factors. Methods: A total of 1482 esophageal cancer patients were enrolled in the study. We investigated the Scored Patient Generated Subjective Global Assessment (PG-SGA) scores, NRS-20 02 scores, Karnofsky performance status scores, anthropometric, and laboratory indicators of patients. Unconditional logistic regression anal-ysis was applied to identify the risk factors of nutritional status. Results: PG-SGA ( >4) and NRS-20 02 ( >3) showed the incidence of malnutrition were 76% and 50%, respectively. In the patients with PG-SGA score >4, the proportion of patients who did not receive any nutritional support was 60%. The incidence of mal-nutrition in females was significantly higher than that in males. Besides, abnormality rates of Red blood cell ( P < 0.001), MAC ( P = 0.037), and MAMC ( P < 0.001) in males was significantly higher than that in fe-males, while abnormality rates of TSF ( P < 0.001) was lower than that in females. After adjusted with the other potential risk factors listed, unconditional logistic regression analysis indicated smoking (odds ratio: 2.868, 95% confidence interval: 1.660-4.954), drinking (OR: 1.726, 95% CI: 1.099-2.712), family history (OR: 1.840, 95% CI: 1.132-2.992), radiotherapy or chemotherapy (OR: 1.594, 95% CI: 1.065-2.387), and pathologi-cal stage (OR: 2.263, 95% CI: 1.084-4.726) might be the risk factors of nutritional status, while nutritional support can reduce the risk of malnutrition. Conclusion: Effective nutritional risk assessment methods and nutritional intervention measures can be adopted according to the research data to improve quality of life of esophageal cancer patients.(c) 2020 Elsevier Inc. All rights reserved.
Impact of malnutrition and nutritional support after gastrectomy in patients with gastric cancer

Min Kyu Kang,Hyuk‐Joon Lee

DOI: https://doi.org/10.1002/ags3.12788

2024-03-17

Annals of Gastroenterological Surgery

Abstract:Malnutrition significantly impacts gastric cancer patients, presenting in forms like cachexia and sarcopenia. In this review, the causes, clinical impact of malnutrition, and nutritional support in gastric cancer patients undergoing gastrectomy will be discussed. Malnutrition, characterized by altered body composition and impaired function, is particularly prevalent among gastric cancer patients, affecting up to 60% of them. Malnutrition in these patients can manifest both before and after surgery, due to factors such as gastric outlet obstruction, cancer cachexia, and anatomical changes. Notably, total gastrectomy (TG) presents the most significant nutritional challenges. However, function‐preserving gastrectomy, such as pylorus‐preserving gastrectomy (PPG) and proximal gastrectomy (PG), have shown promise in improving nutritional outcomes. Effective nutritional risk screening and assessment are vital for identifying patients at risk. Nutritional support not only improves nutritional parameters but also reduces complications, enhances quality of life (QoL) and survival rates. Those unable to maintain more than 50% of the recommended intake for over 7 days are recommended for nutritional support. Common methods of nutritional support include oral nutrition supplements (ONS), enteral nutrition (EN), or parenteral nutrition (PN) depending on the patient's status. Effect of perioperative nutritional support remains controversial. Preoperative interventions including ONS and PN have shown mixed results, with selective benefits in patients with sarcopenia or hypoalbuminaemia, while impact of EN in gastric outlet obstruction patients have been positive. In contrast postoperative support appears to be consistent. Tube feeding after TG has shown improvements, and ONS have been effective in reducing weight loss and improving nutritional biomarkers. PN was also associated with benefits such as weight maintenance and QoL. This review explores the mechanisms, assessment, and clinical impact of malnutrition, emphasizing the importance of nutritional support in gastric cancer patients undergoing gastrectomy.

gastroenterology & hepatology
Bridging gaps in cancer cachexia Care: Current insights and future perspectives

Carlotta Bianchini,Pierluigi Bonomo,Paolo Bossi,Riccardo Caccialanza,Alessandra Fabi

DOI: https://doi.org/10.1016/j.ctrv.2024.102717

IF: 13.608

2024-03-15

Cancer Treatment Reviews

Abstract:Cachexia is characterized by severe weight loss and skeletal muscle depletion, and is a threat to cancer patients by worsening their prognosis. International guidelines set indications for the screening and diagnosis of cancer cachexia and suggest interventions (nutritional support, physical exercise, and pharmacological treatments). Nevertheless, real-life experience not always aligns with such indications. We aimed to review the current state of the field and the main advancements, with a focus on real-life clinical practice from the perspectives of oncologists, nutrition professionals, and radiologists. Pragmatic solutions are proposed to improve the current management of the disease, emphasizing the importance of increasing awareness of clinical nutrition's benefits, fostering multidisciplinary collaboration, promoting early identification of at-risk patients, and leveraging available resources. Given the distinct needs of patients who are receiving oncologic anti-cancer treatments and those in the follow-up phase, the use of tailored approaches is encouraged. The pivotal role of healthcare professionals in managing patients in active treatment is highlighted, while patient and caregiver empowerment should be strengthened in the follow-up phase. Telemedicine and web-based applications represent valuable tools for continuous monitoring of patients, facilitating timely and personalized intervention through effective communication between patients and healthcare providers. These actions can potentially improve the outcomes, well-being, and survival of cancer patients with cachexia.

oncology

Regulation of human B cell growth and differentiation: lessons from the primary immunodeficiencies.

Nutritional Support of Cancer Patients without Oral Feeding: How to Select the Most Effective Technique?

Nutritional support via feeding jejunostomy in esophago-gastric cancers: proposal of a common working strategy based on the available evidence

[Nutritional Support in the Treatment of Patients with Gastrointestinal Cancer].

Nutritional Care of Gastric Cancer Patients with Clinical Outcomes and Complications: A Review

Management of diet in gastrointestinal cancer

Grade of esophageal cancer and nutritional status impact on postsurgery outcomes

The Clinical Value of Nutritional Care before and during Active Cancer Treatment

Role of Nutritional Status in the Treatment Outcome for Esophageal Squamous Cell Carcinoma

Percutaneous endoscopic gastrostomy for nutritional palliation of upper esophageal cancer unsuitable for esophageal stenting

T.F.J. Huda and J.E. Bowman, Age determination from dental microstructure in juveniles: American Journal of Physical Anthropology, 1995 vol. 97: 135-150.

Multiplex Real-Time PCR Assay for Detection of Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Suitable in Regions of High MRSA Endemicity

The Role of Nutritional Support for Cancer Patients in Palliative Care

A Multi-Site, International Audit of Malnutrition Risk and Energy and Protein Intakes in Patients Undergoing Treatment for Head Neck and Esophageal Cancer: Results from INFORM

SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023)

Protein synthesis in axons and its possible functions

[Tumour anorexia--tumour cachexia in case of gastrointestinal tumours: standards and visions]

Malnutrition management in oncology: An expert view on controversial issues and future perspectives

Nutritional Assessment And Risk Factors Associated To Malnutrition In Patients With Esophageal Cancer

Impact of malnutrition and nutritional support after gastrectomy in patients with gastric cancer

Bridging gaps in cancer cachexia Care: Current insights and future perspectives